Form 8-K - Current report:
SEC Accession No. 0001193125-24-275595
Filing Date
2024-12-11
Accepted
2024-12-11 16:22:29
Documents
13
Period of Report
2024-12-11
Items
Item 2.01: Completion of Acquisition or Disposition of Assets

Document Format Files

Seq Description Document Type Size
1 8-K d841090d8k.htm   iXBRL 8-K 24057
  Complete submission text file 0001193125-24-275595.txt   144889

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acad-20241211.xsd EX-101.SCH 2515
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20241211_lab.xml EX-101.LAB 17957
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20241211_pre.xml EX-101.PRE 11241
16 EXTRACTED XBRL INSTANCE DOCUMENT d841090d8k_htm.xml XML 3770
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 241541798
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)